Stocksigma LogoStocksigma Logo

Neuland Laboratories Receives US FDA EIR for Unit 3 Manufacturing Facility

Neuland Laboratories has received an Establishment Inspection Report (EIR) from the US FDA for its Unit 3 manufacturing facility located at Gaddapotharam

Neuland Laboratories Receives US FDA EIR for Unit 3 Manufacturing Facility

Neuland Laboratories Ltd 路 Others (Uncategorized) 路 15 Oct 2026, 3:13 am

Neuland Laboratories Receives US FDA EIR for Unit 3 Manufacturing Facility Neuland Laboratories has received an Establishment Inspection Report (EIR) from the US FDA for its Unit 3 manufacturing facility located at Gaddapotharam Village, Sangareddy District. The inspection, conducted between 10th Aug'26 and 14th Aug'26, has been formally concluded as "closed" by the US FDA, clearing regulatory overhang for the manufacturing site.

Original exchange filing (PDF)

More announcements from Neuland Laboratories Ltd

All Neuland Laboratories Ltd announcements